Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ono act. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103467270B details a safer ozonolysis route for 3-oxocyclobutanecarboxylic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable methods.
Novel patent route from natural anethole offers high purity and cost efficiency for pharmaceutical manufacturing, replacing toxic cyanide processes.
Novel patent CN117303322B details high-purity HFSI preparation avoiding solid byproducts, ensuring supply continuity and cost efficiency for battery manufacturers.
Novel enzymatic process enhances yield and purity while reducing equipment corrosion for reliable supply chains and cost effective manufacturing solutions in global markets.
Novel Sonogashira coupling method for high-purity OLED material. Enhances energy transfer efficiency and supply chain reliability for electronic chemical manufacturing.
Novel synthesis route for monocyclic beta-lactam compounds offering cost reduction and supply chain reliability for pharmaceutical manufacturing partners.
Patent CN110997685B reveals improved ammonolysis for glufosinate intermediates reducing salt load and enhancing supply chain reliability for agrochemical manufacturing.
Novel synthetic route for Landiolol Hydrochloride eliminates column chromatography and toxic reagents ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel 4-step route for Sofosbuvir key intermediate. Avoids hazardous reagents. Reliable supplier for high-purity pharmaceutical intermediates.
Patent CN102557896A discloses high-Δn fluorinated liquid crystal intermediates. Discover scalable synthesis routes for display materials with superior optical anisotropy.
Patent CN102617303B reveals a novel synthesis for high-performance liquid crystal intermediates with large optical anisotropy and low viscosity, offering significant supply chain advantages.
Patent CN107628932B reveals a novel side fluorine tolane diluent synthesis offering superior birefringence and low viscosity for AR display applications.
Novel patent CN108070011A details a robust 7-step synthesis for galactose donors, enabling complex oligosaccharide ester production with improved supply chain reliability.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN103012082B offers high-yield synthesis for supramolecular materials, ensuring supply chain stability and cost efficiency.
Patent CN114230471A details a robust route for 3,4-dichloro-2-fluoroaniline, offering high purity and cost efficiency for Tesevatinib manufacturing supply chains.
Patent CN111960984B reveals a novel ammonia-based synthesis for doripenem intermediates, offering significant cost reduction and improved supply chain reliability for carbapenem manufacturers.
Advanced synthesis of chiral heptenone intermediates via ozonolysis and HWE reaction. Offers cost-effective, scalable production for statin APIs with superior yield.
Patent CN113444117A details a star-shaped BODIPY-PDI derivative synthesis via Sonogashira coupling, offering enhanced solubility and absorption for electronic chemical manufacturing.
Novel process for HMG-CoA inhibitor intermediates offering high stereoselectivity and scalable production for pharmaceutical supply chains.